科兴制药：累计回购约127万股

Group 1 - The core point of the article is that Sinovac Biotech has announced a share buyback program, having repurchased approximately 1.27 million shares, which represents 0.63% of its total share capital, with a total expenditure of approximately RMB 47.38 million [2] - The highest price for the repurchased shares was RMB 43.5 per share, while the lowest price was RMB 23.14 per share [2] - For the year 2024, the revenue composition of Sinovac Biotech is reported to be 99.59% from pharmaceutical manufacturing, 0.25% from other businesses, and 0.16% from other sources [2]